Multimerization of a chimeric anti-CD20 single-chain Fv-Fc fusion protein is mediated through variable domain exchange
Open Access
- 1 December 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Protein Engineering, Design and Selection
- Vol. 14 (12), 1025-1033
- https://doi.org/10.1093/protein/14.12.1025
Abstract
A series of single-chain anti-CD20 antibodies was produced by fusing single-chain Fv (scFv) with human IgG1 hinge and Fc regions, designated scFv-Fc. The initial scFv-Fc construct was assembled using an 18 amino acid (aa) linker between the antibody light- and heavy-chain variable regions, with the Cys residue in the upper hinge region (Kabat 233) mutagenized to Ser. Anti-CD20 scFv-Fc retained specific binding to CD20-positive cells and was active in mediating complement-dependent cytolysis. Size-exclusion HPLC analysis revealed that the purified scFv-Fc included multimeric as well as monomeric components. Variant scFv-Fcs were constructed incorporating four different hinges between the scFv and Fc regions, or three different linkers in the scFv domain. All formed multimers, with the highest level of multimerization found in the scFv-Fc with the shortest linker (8 aa). Elimination of an unusual salt bridge between residues L38 and H89 in the VL-VH domain interface failed to reduce the formation of higher order forms. Structural analysis of the scFv-Fc constructed with 18 or 8 aa linkers by pepsin or papain cleavage suggested the proteins contained a form in which scFv units had cross-paired to form a `diabody'. Thus, domain exchange or cross-pairing appears to be the basis of the observed multimerization.Keywords
This publication has 33 references indexed in Scilit:
- Change in dimerization mode by removal of a single unsatisfied polar residue located at the interface.Protein Science, 2000
- Reengineering immunoglobulin domain interactions by introduction of charged residuesProtein Engineering, Design and Selection, 1998
- Properties of a single-chain antibody containing different linker peptidesProtein Engineering, Design and Selection, 1995
- CD20: a regulator of cell-cycle progression of B lymphocytesImmunology Today, 1994
- Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3Protein Engineering, Design and Selection, 1994
- An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stabilityProtein Engineering, Design and Selection, 1993
- High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable MarkerNature Biotechnology, 1992
- Expression of antibody genes in nonlymphoid mammalian cellsMethods, 1991
- Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extensionGene, 1989
- Domain association in immunoglobulin moleculesJournal of Molecular Biology, 1985